219 related articles for article (PubMed ID: 34879282)
1. Parity-induced changes to mammary epithelial cells control NKT cell expansion and mammary oncogenesis.
Hanasoge Somasundara AV; Moss MA; Feigman MJ; Chen C; Cyrill SL; Ciccone MF; Trousdell MC; Vollbrecht M; Li S; Kendall J; Beyaz S; Wilkinson JE; Dos Santos CO
Cell Rep; 2021 Dec; 37(10):110099. PubMed ID: 34879282
[TBL] [Abstract][Full Text] [Related]
2. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy reprograms the epigenome of mammary epithelial cells and blocks the development of premalignant lesions.
Feigman MJ; Moss MA; Chen C; Cyrill SL; Ciccone MF; Trousdell MC; Yang ST; Frey WD; Wilkinson JE; Dos Santos CO
Nat Commun; 2020 May; 11(1):2649. PubMed ID: 32461571
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.
Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H
Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366
[TBL] [Abstract][Full Text] [Related]
5. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
7. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
8. Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice.
Mastini C; Becker PD; Iezzi M; Curcio C; Musiani P; Forni G; Cavallo F; Guzmán CA
Curr Cancer Drug Targets; 2008 May; 8(3):230-42. PubMed ID: 18473736
[TBL] [Abstract][Full Text] [Related]
9. Alveolar progenitor cells develop in mouse mammary glands independent of pregnancy and lactation.
Booth BW; Boulanger CA; Smith GH
J Cell Physiol; 2007 Sep; 212(3):729-36. PubMed ID: 17443685
[TBL] [Abstract][Full Text] [Related]
10. Immune compartmentalization of T cell subsets in chemically-induced breast cancer.
Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D
Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319
[TBL] [Abstract][Full Text] [Related]
11. Influence of normal mammary epithelium on breast cancer progression: the protective role of early pregnancy.
Martins FC; Botelho MF; Cabrita AM; de Oliveira CF
Tumori; 2010; 96(6):999-1003. PubMed ID: 21388065
[TBL] [Abstract][Full Text] [Related]
12. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
Mixon M; Kittrell F; Medina D
Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440
[TBL] [Abstract][Full Text] [Related]
13. Exposure to excess estradiol or leptin during pregnancy increases mammary cancer risk and prevents parity-induced protective genomic changes in rats.
de Assis S; Wang M; Jin L; Bouker KB; Hilakivi-Clarke LA
Cancer Prev Res (Phila); 2013 Nov; 6(11):1194-211. PubMed ID: 24169961
[TBL] [Abstract][Full Text] [Related]
14. p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis.
Yallowitz AR; Alexandrova EM; Talos F; Xu S; Marchenko ND; Moll UM
Cell Death Differ; 2014 Apr; 21(4):645-54. PubMed ID: 24440910
[TBL] [Abstract][Full Text] [Related]
15. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
16. Leaving home early: reexamination of the canonical models of tumor progression.
Weinberg RA
Cancer Cell; 2008 Oct; 14(4):283-4. PubMed ID: 18835030
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development.
Sandrock I; Ziętara N; Łyszkiewicz M; Oberdörfer L; Witzlau K; Krueger A; Prinz I
PLoS One; 2015; 10(12):e0145010. PubMed ID: 26673421
[TBL] [Abstract][Full Text] [Related]
18. CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo.
Tian G; Courtney AN; Jena B; Heczey A; Liu D; Marinova E; Guo L; Xu X; Torikai H; Mo Q; Dotti G; Cooper LJ; Metelitsa LS
J Clin Invest; 2016 Jun; 126(6):2341-55. PubMed ID: 27183388
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
[TBL] [Abstract][Full Text] [Related]
20. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
